Non Peptidic v&bgr;3 Antagonists: Recent Developments

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|1|51-70

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.1, 2005-01, pp. : 51-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multimodality Imaging of Tumor Integrin v&bgr;3 Expression

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of V&bgr;7.1_H3F7 as a Therapeutic Gene Encoding TCR Specific to Hepatocellular Carcinoma

By  

Current Gene Therapy, Vol. 14, Iss. 5, 2014-10 ,pp. : 389-399

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in the Design of Orally Bioavailable &bgr;3-Adrenergic Receptor Agonists

By  

Current Medicinal Chemistry, Vol. 13, Iss. 1, 2006-01 ,pp. : 25-37

Bentham Science Publishers

Access to resources Recommend Favorite

v&bgr;3 Integrin antagonists as inhibitors of bone resorption

By Hartman G.D.   Duggan M.E.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1281-1291

Informa Healthcare

Access to resources Recommend Favorite

Non-Peptidic GnRH Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 11, Iss. 22, 2004-11 ,pp. : 3017-3028

Bentham Science Publishers

Access to resources Recommend Favorite